MAX Chat
Share chart Moderna
Extended chart
Simple chart
About Moderna
Moderna — американская биотехнологическая компания, занимающаяся исследованием и разработкой лекарств на основе исключительно РНК-мессенджера.В основе компании идея с mRNA — мессенджер РНК. Искуственно создается возбудитель вируса и создается препарат, который тренирует иммунную систему. Надо только расшифровать геном вируса, загрузить в комп, и на выходе будет состав вакцины. И так практически с любым вирусом. Проблема с доставкой этого мРНК в клетки человека. У Модерны 21 разработка, 10 проходят клинические испытания и НОЛЬ одобренных препаратов.
Main settings
IPO date
2018-12-07
ISIN
US60770K1079
Industry
Biotechnology
Sector
Health Care
Валюта
usd
Валюта отчета
usd
Див.доход ао
0
Сайт
Grade
Underestimation
| Title | Value | Grade |
| P/S | 4.67 | 3 |
| P/BV | 1.39 | 9 |
| P/E | 8.96 | 9 |
Efficiency
| Title | Value | Grade |
| ROA | -21.87 | 0 |
| ROE | -28.77 | 0 |
| ROIC | 131.22 | 10 |
Dividends
| Title | Value | Grade |
| Dividend yield | 0 | 0 |
| DSI | 0 | 0 |
| Average dividend growth | 0 | 0 |
Debt
| Title | Value | Grade |
| Debt/EBITDA | -0.2092 | 10 |
| Debt/Ratio | 0.0502 | 10 |
| Debt/Equity | 0.2973 | 10 |
Growth impulse
| Title | Value | Grade |
| Yield Revenue, % | 1078.87 | 10 |
| Yield Ebitda, % | 344.76 | 10 |
| Yield EPS, % | 373.13 | 10 |
Prices
| Price | Min. | Max. | Change | Changes in the industry | Changes in the index | |
| Yesterday | 30.49 $ | 0 $ | 0 $ | -1.94 % | 0 % | 0 % |
| Week | 27.16 $ | 0 $ | 0 $ | +10.09 % | 0 % | 0 % |
| Month | 26.12 $ | 25.67 $ | 30.49 $ | +14.47 % | 0 % | 0 % |
| Three month | 26.54 $ | 23.65 $ | 30.49 $ | +12.66 % | 0 % | 0 % |
| Half a year | 35.75 $ | 23.65 $ | 44.94 $ | -16.36 % | 0 % | 0 % |
| Year | 68.28 $ | 23.65 $ | 122.5 $ | -56.21 % | 0 % | 0 % |
| 3 years | 123.64 $ | 23.65 $ | 210.04 $ | -75.82 % | 0 % | 0 % |
| 5 years | 132.57 $ | 23.65 $ | 484.47 $ | -77.45 % | 0 % | 0 % |
| 10 years | 12.67 $ | 12.67 $ | 484.47 $ | +215.86 % | 0 % | 0 % |
| Year to date | 34.98 $ | 23.65 $ | 47.53 $ | -14.52 % | 0 % | 0 % |
Insider trading
Main owners
Contained in ETF
Similar companies
P/E & P/BV
Company management
| Head | Job title | Payment | Year of birth |
| Mr. Stephane Bancel | CEO & Director | 4.55M | 1973 (52 years) |
| Ms. Lavina Talukdar CFA | Senior VP & Head of Investor Relations | N/A | |
| Ms. Shannon Thyme Klinger | Chief Legal Officer & Corporate Secretary | 1.39M | 1971 (54 years) |
| Dr. Stephen Hoge M.D. | President | 1.92M | 1977 (48 years) |
| Mr. James M. Mock | Chief Financial Officer | 1.4M | 1977 (48 years) |
| Dr. Jerh Collins Ph.D. | Chief Technical Operations & Quality Officer | N/A | 1967 (58 years) |
| Mr. Brad Miller | Chief Information Officer | N/A | 1974 (51 year) |
| Colleen Hussey | Senior Director of Corporate Communications | N/A | |
| Ms. Tracey Franklin | Chief Human Resources Officer | N/A | 1981 (44 years) |
| Dr. Melanie Ivarsson M.B.A., Ph.D. | Chief Development Officer | N/A |
About company
Address: United States, Cambridge, 200 Technology Square - Open in google maps, Open in yandex maps
Website: http://www.modernatx.com
Website: http://www.modernatx.com
